| Follow-up visits | |||||||
---|---|---|---|---|---|---|---|---|
PROTOCOL ACTIVITIES | Screening Visit | Initial Visit | Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Final Visit |
SCHEDULE OF VISITS |  | 0 | 15 ± 5 | 30 ± 5 | 45 ± 5 | 60 ± 5 | 75 ± 5 | 90 ± 5 |
Clinical History | X | X | X | X | X | X | X | X |
Physical Examination | X | X | X | X | X | X | X | X |
Inclusion/Exclusion criteria | X | Â | Â | Â | Â | Â | Â | Â |
Informed Consent | X | Â | Â | Â | Â | Â | Â | Â |
Clinical assessment of vascular compromise | X | X | X | X | X | X | X | X |
Clinical assessment of neuropathic compromise | Â | X | Â | Â | Â | Â | Â | X |
Laboratory tests | Â | X | Â | Â | Â | Â | Â | X |
Ankle/arm index | X | Â | Â | Â | Â | Â | Â | Â |
Randomization | Â | X | Â | Â | Â | Â | Â | Â |
Treatment administration | Â | X | X | X | X | X | X | Â |
Clinical assessment of the lesion | X | X | X | X | X | X | X | X |
Measurement of ulcers | X | X | X | X | X | X | X | X |
Photographic registration | Â | X | X | X | X | X | X | X |
Education of patients | X | X | X | X | X | X | X | X |
Documentation of adverse events | X | X | X | X | X | X | X | X |
Recording of concomitant medications | X | X | X | X | X | X | X | X |